Knowles Corp: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 1, 2024 and accepted by EDGAR at May 1, 2024, 17:01 ET.
Management's discussion and analysis
As filed, 37,105 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis should be read in conjunction with our Consolidated Financial Statements and related Notes included elsewhere in this Quarterly Report on Form 10-Q.
Overview
We are a market leader and global provider of high performance capacitors and radio frequency ("RF") filtering products, balanced armature speakers, advanced micro-acoustic microphones, and audio solutions, serving the medtech, defense, electric vehicle, industrial, communications, and consumer electronics markets. Our focus on the customer, combined with unique technology, proprietary manufacturing techniques, and global operational expertise, enables us to deliver innovative solutions across multiple applications. References to "Knowles," the "Company," "we," "our," or "us" refer to Knowles Corporation and its consolidated subsidiaries, unless the context otherwise requires.
We sell our products directly to original equipment manufacturers ("OEMs") and to their contract manufacturers and suppliers and through distributors worldwide.
Recent Developments
On September 18, 2023, we announced that we are reviewing strategic alternatives for the CMM business. This includes a range of possibilities, such as: a potential sale, restructuring the business, as well as continuing to operate the business as is. No assurance can be given that any transaction or other strategic outcomes will result from the review. Further, there can be no assurance that the outcome of the strategic alternative review will result in our being able to recover the carrying value of the CMM segment. While the review is progressing, we have not set a timetable for the conclusion of the strategic review and do not intend to comment on or provide updates regarding these matters unless and until we determine that further disclosure is appropriate or required.
On November 1, 2023, we acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $259.8 million, which equated to a total fair value of consideration transferred of $246.8 million. The acquired business is a manufacturer of film, electrolytic, and mica capacitors used in medtech, defense, and industrial electrification applications. The acquisition's operations are included in the PD segment. For additional information, refer to Note 3. Acquisition to our Consolidated Financial Statements under Part I, Item 1, "Financial Statements."
Non-GAAP Financial Measures
In addition to the GAAP financial measures included in this item, we have presented certain non-GAAP financial measures. We use non-GAAP measures as supplements to our GAAP results of operations in evaluating certain aspects of our business, and our executive management team and Board of Directors focus on non-GAAP items as key measures of our performance for business planning purposes. These measures assist us in comparing our performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in our opinion, do not reflect our core operating performance. We believe that our presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that we use internally for purposes of assessing our core operating performance. The Company does not consider these non-GAAP financial measures to be a substitute for the information provided by GAAP financial results. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, see the reconciliation included herein.
Results of Operations for the Three Months Ended March 31, 2024 compared with the Three Months Ended March 31, 2023
(in millions, except per share amounts)
| Three Months Ended March 31, 2024 | 2023 | |
|---|---|---|
| Revenues | $196.4 | $144.3 |
| Gross profit | $69.9 | $53.8 |
| Non-GAAP gross profit | $74.7 | $54.4 |
| Earnings (loss) before interest and income taxes | $10.1 | $(3.3) |
| Adjusted earnings before interest and income taxes | $25.7 | $8.1 |
| Provision for income taxes | $3.2 | $1.1 |
| Non-GAAP provision for income taxes | $2.7 | $2.2 |
| Net earnings (loss) | $2.5 | $(5.2) |
| Non-GAAP net earnings | $18.6 | $5.1 |
| Diluted earnings (loss) per share | $0.03 | $(0.06) |
| Non-GAAP diluted earnings per share | $0.20 | $0.05 |
Revenues
Revenues for the first quarter of 2024 were $196.4 million, compared with $144.3 million for the first quarter of 2023, an increase of $52.1 million or 36.1%. PD revenues increased $20.6 million due to our acquisition of the CD business, partially offset by lower demand from the medtech, industrial, and communication markets in our legacy PD business as a result of continued demand weakness associated with excess customer and channel inventory. CMM revenues increased $19.9 million, primarily due to higher demand in the ear, mobile, and computing markets, partially offset by lower average pricing on mature products. MSA revenues increased $11.6 million, primarily due to higher shipping volumes of hearing health products driven by stronger end market demand. In addition, revenues in the first quarter of 2023 were unfavorably impacted by financial incentives offered to customers in the fourth quarter of 2022, which resulted in higher shipping volumes in the fourth quarter of 2022 and lower revenues in the first quarter of 2023.
Cost of Goods Sold
Cost of goods sold ("COGS") for the first quarter of 2024 was $125.5 million, compared with $90.4 million for the first quarter of 2023, an increase of $35.1 million or 38.8%. This increase was primarily due to our acquisition of CD, higher shipping volumes, and lower factory capacity utilization in our legacy PD business, partially offset by product cost reductions and favorable foreign currency changes.
Restructuring Charges
During the first quarter of 2024, we recorded restructuring charges of $1.8 million related to headcount reductions and $0.7 million for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations, all within our PD segment. For additional information, refer to Note 7. Restructuring and Related Activities to our Consolidated Financial Statements.
During the first quarter of 2023, we recorded restructuring charges of $0.8 million related to headcount reductions in our CMM segment and $0.3 million for other costs. For additional information, refer to Note 7. Restructuring and Related Activities to our Consolidated Financial Statements.
Gross Profit and Non-GAAP Gross Profit
Gross profit for the first quarter of 2024 was $69.9 million, compared with $53.8 million for the first quarter of 2023, an increase of $16.1 million or 29.9%. Gross profit margin (gross profit as a percentage of revenues) for the first quarter of 2024 was 35.6%, compared with 37.3% for the first quarter of 2023. The increase in gross profit was primarily due to higher shipping volumes, product cost reductions, our acquisition of CD, favorable foreign currency changes, and higher factory capacity utilization in our CMM segment, partially offset by lower average pricing on mature products shipped into the mobile market, lower factory capacity utilization in our legacy PD business, our acquisition-related costs of CD, and increased restructuring charges. The decrease in gross profit margin was primarily due to lower average pricing on mature products shipped into the mobile market, lower factory capacity utilization in our legacy PD business, our acquisition-related costs of CD, and increased restructuring charges, partially offset by product cost reductions, favorable foreign currency changes, and higher factory capacity utilization in our CMM segment.
Non-GAAP gross profit for the first quarter of 2024 was $74.7 million, compared with $54.4 million for the first quarter of 2023, an increase of $20.3 million or 37.3%. Non-GAAP gross profit margin (non-GAAP gross profit as a percentage of revenues) for the first quarter of 2024 was 38.0%, compared with 37.7% for the first quarter of 2023. The increase in non-GAAP gross profit was primarily due to higher shipping volumes, product cost reductions, our acquisition of CD, favorable foreign currency changes, and higher factory capacity utilization in our CMM segment, partially offset by lower average pricing on mature products shipped into the mobile market and lower factory capacity utilization in our legacy PD business. The increase in non-GAAP gross profit margin was primarily due to product cost reductions, favorable foreign currency changes, and higher factory capacity utilization in our CMM segment, partially offset by lower average pricing on mature products shipped into the mobile market and lower factory capacity utilization in our legacy PD business.
Research and Development Expenses
Research and development expenses for the first quarter of 2024 were $20.6 million, compared with $20.0 million for the first quarter of 2023, an increase of $0.6 million or 3.0%. Research and development expenses as a percentage of revenues for the first quarter of 2024 and 2023 were 10.5% and 13.9%, respectively. The increase in expenses was primarily driven by our acquisition of the CD business that increased expenses in our PD segment and additional development activities in our MSA segment, partially offset by reduced spending in our CMM segment driven by the benefits of prior year restructuring actions as we continue to shift our focus and spending to our higher margin businesses. The decrease in expenses as a percentage of revenues was driven by our higher revenues.
Selling and Administrative Expenses
Selling and administrative expenses for the first quarter of 2024 were $43.5 million, compared with $33.8 million for the first quarter of 2023, an increase of $9.7 million or 28.7%. Selling and administrative expenses as a percentage of revenues for the first quarter of 2024 and 2023 were 22.1% and 23.4%, respectively. The increase in expenses was primarily driven by our acquisition of CD. The decrease in expenses as a percentage of revenues was driven by higher revenues.
Interest Expense, net
Interest expense for the first quarter of 2024 was $4.4 million, compared with $0.8 million for the first quarter of 2023, an increase of $3.6 million. The increase is primarily due to imputed interest expense on our Seller Note from the CD acquisition, a higher outstanding revolving credit facility balance, and higher interest rates during the first quarter of 2024. For additional information on borrowings and interest expense, refer to Note 8. Borrowings to our Consolidated Financial Statements.
Other (Income) Expense, net
Other income for the first quarter of 2024 was $0.4 million, compared with expense of $2.3 million for the first quarter of 2023, a change of $2.7 million. Income in 2024 primarily represents unrealized gains in our investment balances. Expense in 2023 primarily represents unfavorable impacts from foreign currency exchange rate changes, partially offset by the unrealized gains in our investment balances.
Gain on Sale of Asset, net
The gain on sale of asset of $5.4 million is related to the sale of intellectual property previously used in the Intelligent Audio product line, which is included the CMM segment. For additional information, refer to Note 6. Goodwill and Other Intangible Assets.
Provision for Income Taxes and Non-GAAP Provision for Income Taxes
The effective tax rate ("ETR") for the first quarter of 2024 and 2023 was 56.1% and (26.8)%, respectively. The ETR for the first quarter of 2024 and 2023 includes discrete items totaling $0.8 million and $0.6 million of tax expense, respectively. The discrete items impacting the tax provision for 2024 and 2023 are primarily attributable to stock-based compensation. Absent the discrete items, the ETR for the first quarter of 2024 and 2023 was 42.1% and (12.2)%, respectively. The Company accrues taxes in various countries where it generates income and applies a valuation allowance in other jurisdictions, which resulted in the provision for the first quarter of 2024 and 2023, respectively. The change in the ETR was due to the mix of earnings and losses by taxing jurisdictions and net discrete items.
The non-GAAP ETR for the first quarter of 2024 and 2023 was 12.7% and 30.1%, respectively. The non-GAAP ETR includes discrete items totaling $0.7 million and $0.9 million of tax expense for the first quarter of 2024 and 2023, respectively. Absent the discrete items, the non-GAAP ETR for the first quarter of 2024 and 2023 was 9.4% and 17.8%, respectively. The change in the non-GAAP ETR was primarily due to increased utilization of foreign tax credits compared to the prior year.
Net Earnings (Loss)
Net earnings for the first quarter of 2024 were $2.5 million, compared with a $5.2 million loss for the first quarter of 2023, an increase of $7.7 million. As described above, the increase is primarily due to higher gross profit and the gain on sale of asset, partially offset by higher operating expenses and interest expense.
Earnings (Loss) and Adjusted Earnings Before Interest and Income Taxes
Earnings before interest and income taxes ("EBIT") for the first quarter of 2024 was $10.1 million, compared with a $3.3 million loss for the first quarter of 2023, an increase of $13.4 million. EBIT margin (EBIT as a percentage of revenues) for the first quarter of 2024 was 5.1%, compared with (2.3)% for the first quarter of 2023. The change is primarily due to higher gross profit and the gain on sale of asset, partially offset by higher operating expenses.
Adjusted earnings before interest and income taxes ("Adjusted EBIT") for the first quarter of 2024 was $25.7 million, compared with $8.1 million for the first quarter of 2023, an increase of $17.6 million. Adjusted EBIT margin (Adjusted EBIT as a percentage of revenues) for the first quarter of 2024 was 13.1%, compared with 5.6% for the first quarter of 2023. The increases were primarily due to higher non-GAAP gross profit, partially offset by higher non-GAAP operating expenses.
Diluted Earnings (Loss) per Share and Non-GAAP Diluted Earnings per Share
Diluted earnings per share was $0.03 for the first quarter of 2024, compared with loss per share of $0.06 for the first quarter of 2023, an increase of $0.09. As described above, the increase is primarily due to higher gross profit and the gain on sale of asset, partially offset by operating expenses and interest expense.
Non-GAAP diluted earnings per share was $0.20 for the first quarter of 2024, compared with $0.05 for the first quarter of 2023, an increase of $0.15. As described above, the increase was primarily due to higher non-GAAP gross profit partially offset by higher non-GAAP operating expenses and interest expense.
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures (1)
(in millions, except per share amounts)
| Three Months Ended March 31, 2024 | 2023 | |
|---|---|---|
| Gross profit | $69.9 | $53.8 |
| Stock-based compensation expense | 0.5 | 0.5 |
| Restructuring charges | 1.0 | 0.1 |
| Production transfer costs (2) | 0.8 | — |
| Acquisition-related costs (3) | 1.4 | — |
| Other (4) | 1.1 | — |
| Non-GAAP gross profit | $74.7 | $54.4 |
| Net earnings (loss) | $2.5 | $(5.2) |
| Interest expense, net | 4.4 | 0.8 |
| Provision for income taxes | 3.2 | 1.1 |
| Earnings (loss) before interest and income taxes | 10.1 | (3.3) |
| Stock-based compensation expense | 6.7 | 7.8 |
| Intangibles amortization expense | 5.9 | 2.9 |
| Restructuring charges | 2.5 | 1.1 |
| Production transfer costs (2) | 0.8 | — |
| Acquisition-related costs (3) | 4.2 | — |
| Gain on sale of asset (5) | (5.4) | — |
| Other (4) | 0.9 | (0.4) |
| Adjusted earnings before interest and income taxes | $25.7 | $8.1 |
| Provision for income taxes | $3.2 | $1.1 |
| Income tax effects of non-GAAP reconciling adjustments (6) | (0.5) | 1.1 |
| Non-GAAP provision for income taxes | $2.7 | $2.2 |
| Net earnings (loss) | $2.5 | $(5.2) |
| Non-GAAP reconciling adjustments (7) | 15.6 | 11.4 |
| Income tax effects of non-GAAP reconciling adjustments (6) | (0.5) | 1.1 |
| Non-GAAP net earnings | $18.6 | $5.1 |
| Diluted earnings (loss) per share | $0.03 | $(0.06) |
| Earnings per share non-GAAP reconciling adjustment | 0.17 | 0.11 |
| Non-GAAP diluted earnings per share | $0.20 | $0.05 |
| Diluted average shares outstanding | 90.5 | 91.4 |
| Non-GAAP adjustment (8) | 2.2 | 3.3 |
| Non-GAAP diluted average shares outstanding (8) | 92.7 | 94.7 |
24
(1) In addition to the GAAP financial measures included herein, Knowles has presented certain non-GAAP financial measures that exclude certain amounts that are included in the most directly comparable GAAP measures. Knowles believes that non-GAAP measures are useful as supplements to its GAAP results of operations to evaluate certain aspects of its operations and financial performance, and its management team primarily focuses on non-GAAP items in evaluating Knowles' performance for business planning purposes. Knowles also believes that these measures assist it with comparing its performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in Knowles' opinion, do not reflect its core operating performance. Knowles believes that its presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that Knowles uses internally for purposes of assessing its core operating performance.
(2) Production transfer costs represent duplicate costs incurred to migrate manufacturing to facilities primarily within the United States. These amounts are included in the corresponding Gross profit and Earnings (loss) before interest and income taxes for each period presented.
(3) These expenses are related to the acquisition of CD by the PD segment. These expenses include ongoing costs to facilitate integration, the amortization of fair value adjustments to inventory, and costs incurred by the Company to carry out this transaction.
(4) Other expenses include non-recurring professional service fees related to an execution of various reorganization projects, foreign currency exchange rate impacts on restructuring balances, and the ongoing net lease cost (income) related to facilities not used in operations.
(5) This gain is related to the sale of intellectual property previously used in the Intelligent Audio product line, which is included within the CMM segment.
(6) Income tax effects of non-GAAP reconciling adjustments are calculated using the applicable tax rates in the jurisdictions of the underlying adjustments.
(7) The non-GAAP reconciling adjustments are those adjustments made to reconcile Earnings (loss) before interest and income taxes to Adjusted earnings before interest and income taxes.
(8) The number of shares used in the diluted per share calculations on a non-GAAP basis excludes the impact of stock-based compensation expense expected to be incurred in future periods and not yet recognized in the financial statements, which would otherwise be assumed to be used to repurchase shares under the GAAP treasury stock method.
Segment Results of Operations for the Three Months Ended March 31, 2024 compared with the Three Months Ended March 31, 2023
The following is a summary of the results of operations of our three reportable segments: Precision Devices, Medtech & Specialty Audio, and Consumer MEMS Microphones.
See Note 14. Segment Information to the Consolidated Financial Statements for (i) a reconciliation of segment revenues to our consolidated revenues and (ii) a reconciliation of segment earnings before interest and income taxes to our consolidated earnings.
Precision Devices
(in millions)
| Three Months Ended March 31, 2024 | Percent of Revenues | 2023 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $74.3 | $53.7 | ||
| (Loss) earnings before interest and income taxes | $(2.1) | (2.8)% | $10.7 | 19.9% |
| Stock-based compensation expense | 0.1 | 0.9 | ||
| Intangibles amortization expense | 4.4 | 1.4 | ||
| Restructuring charges | 2.5 | — | ||
| Production transfer costs (1) | 0.8 | — | ||
| Acquisition-related costs (2) | 3.6 | — | ||
| Other | 0.5 | — | ||
| Adjusted earnings before interest and income taxes | $9.8 | 13.2% | $13.0 | 24.2% |
| (1) Production transfer costs represent costs incurred to migrate manufacturing to existing facilities. | ||||
| (2) These expenses are related to the acquisition of CD. These expenses include ongoing costs to facilitate integration and the amortization of fair value adjustments to inventory. |
Revenues
PD revenues were $74.3 million for the first quarter of 2024, compared with $53.7 million for the first quarter of 2023, an increase of $20.6 million or 38.4%. Revenues increased due to our acquisition of the CD business, partially offset by lower demand from the medtech, industrial, and communication markets in our legacy PD business as a result of continued demand weakness associated with excess customer and channel inventory.
(Loss) Earnings and Adjusted Earnings Before Interest and Income Taxes
PD loss before interest and income taxes was $2.1 million for the first quarter of 2024, compared with earnings of $10.7 million for the first quarter of 2023, a decrease of $12.8 million. EBIT margin for the first quarter of 2024 was (2.8)%, compared to 19.9% for the first quarter of 2023. The decreases were primarily due to lower gross profit margin and increased operating expenses, partially offset by higher revenues. The gross profit margin decrease was primarily driven by lower factory capacity utilization in our legacy PD business, higher restructuring charges, and the acquisition of CD. In addition, gross profit margins decreased as a result of acquisition-related and production transfer costs associated with the CD business. The increase in operating expenses was primarily driven by the acquisition of the CD business, which includes higher intangible amortization expenses.
PD Adjusted EBIT was $9.8 million for the first quarter of 2024, compared with $13.0 million for the first quarter of 2023, a decrease of $3.2 million. Adjusted EBIT margin for the first quarter of 2024 was 13.2%, compared with 24.2% for the first quarter of 2023. The decreases were primarily due to lower non-GAAP gross profit margin, partially offset by higher revenues. The non-GAAP gross profit margin decrease was primarily driven by lower factory capacity utilization in our legacy PD business and the acquisition of CD.
MedTech & Specialty Audio
(in millions)
| Three Months Ended March 31, 2024 | Percent of Revenues | 2023 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $57.1 | $45.5 | ||
| Earnings before interest and income taxes | $22.7 | 39.8% | $11.4 | 25.1% |
| Stock-based compensation expense | 1.0 | 0.9 | ||
| Adjusted earnings before interest and income taxes | $23.7 | 41.5% | $12.3 | 27.0% |
Revenues
MSA revenues were $57.1 million for the first quarter of 2024, compared with $45.5 million for the first quarter of 2023, an increase of $11.6 million or 25.5%. Revenues increased primarily due to higher shipping volumes of hearing health products driven by stronger end market demand. In addition, revenues in first quarter of 2023 were unfavorably impacted by financial incentives offered to customers in the fourth quarter of 2022 which resulted in higher shipping volumes in the fourth quarter of 2022 and lower revenues in the first quarter of 2023.
Earnings and Adjusted Earnings Before Interest and Income Taxes
MSA EBIT was $22.7 million for the first quarter of 2024, compared with $11.4 million for the first quarter of 2023, an increase of $11.3 million or 99.1%. EBIT margin for the first quarter of 2024 was 39.8%, compared with 25.1% for the first quarter of 2023. The increases were primarily due to higher revenues and gross profit margins. The higher gross profit margin was driven by favorable product mix and product cost reductions.
MSA Adjusted EBIT was $23.7 million for the first quarter of 2024, compared with $12.3 million for the first quarter of 2023, an increase of $11.4 million. Adjusted EBIT margin for the first quarter of 2024 was 41.5%, compared to 27.0% for the first quarter of 2023. The increases were primarily due to higher revenues and non-GAAP gross profit margins. The higher non-GAAP gross profit margin was driven by favorable product mix and product cost reductions.
Consumer MEMS Microphones
(in millions)
| Three Months Ended March 31, 2024 | Percent of Revenues | 2023 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $65.0 | $45.1 | ||
| Earnings (loss) before interest and income taxes | $5.3 | 8.2% | $(8.2) | (18.2)% |
| Stock-based compensation expense | 1.6 | 1.7 | ||
| Intangibles amortization expense | 1.5 | 1.5 | ||
| Restructuring charges | — | 0.8 | ||
| Gain on sale of asset, net | (5.4) | — | ||
| Other (1) | — | (0.4) | ||
| Adjusted earnings (loss) before interest and income taxes | $3.0 | 4.6% | $(4.6) | (10.2)% |
| (1) Other represents the ongoing net lease income related to facilities not used in operations. |
Revenues
CMM revenues were $65.0 million for the first quarter of 2024, compared with $45.1 million for the first quarter of 2023, an increase of $19.9 million or 44.1%. Revenues increased primarily due to higher demand in the ear, mobile, and computing markets, partially offset by lower average pricing on mature products.
Earnings (Loss) and Adjusted Earnings (Loss) Before Interest and Income Taxes
CMM EBIT was $5.3 million for the first quarter of 2024, compared with a $8.2 million loss for the first quarter of 2023, an increase of $13.5 million. EBIT margin for the first quarter of 2024 was 8.2%, compared with (18.2)% for the first quarter of 2023. The increase was primarily due to higher revenues, the gain on sale of asset, and higher gross profit margins. The higher gross profit margin was driven by product cost reductions, favorable foreign currency changes, and increased factory capacity utilization, partially offset by lower average pricing on mature products shipped into the mobile market and unfavorable product mix.
CMM Adjusted EBIT was $3.0 million for the first quarter of 2024, compared with a $4.6 million loss for the first quarter of 2023, an increase of $7.6 million. Adjusted EBIT margin for the first quarter of 2024 was 4.6%, compared to (10.2)% for the first quarter of 2023. The increases in Adjusted EBIT were primarily due to higher revenues and higher non-GAAP gross profit margins. The higher non-GAAP gross profit margin was driven by product cost reductions, favorable foreign currency changes, and increased factory capacity utilization, partially offset by lower average pricing on mature products shipped into the mobile market and unfavorable product mix.
Liquidity and Capital Resources
Historically, we have generated and expect to continue to generate positive cash flow from operations. Our ability to fund our operations and capital needs will depend on our ongoing ability to generate cash from operations and access to capital markets. We believe that our future cash flow from operations and access to capital markets will provide adequate resources to fund our working capital needs, capital expenditures, strategic investments, and share repurchases. We have secured a revolving line of credit in the United States from a syndicate of commercial banks to provide additional liquidity. Furthermore, if we were to require additional cash above and beyond our cash on the balance sheet, the free cash flow generated by the business, and availability under our revolving credit facility, we would most likely seek to raise long-term financing through the U.S. debt or bank markets.
Due to the global nature of our operations, a significant portion of our cash is generated and typically held outside the United States. Our cash and cash equivalents totaled $122.1 million and $87.3 million at March 31, 2024 and December 31, 2023, respectively. Of these amounts, cash held by our non-U.S. operations totaled $88.1 million and $71.8 million as of March 31, 2024 and December 31, 2023, respectively. To the extent we repatriate these funds to the U.S., we may be required to pay U.S. state income taxes and applicable foreign withholding taxes on those amounts during the period when such repatriation occurs. Management will continue to reassess our need to repatriate the earnings of our foreign subsidiaries. We expect to reduce our cash balance in the second half of the year, primarily driven by the payment of the Seller Note related to the CD acquisition, share repurchases, and debt reduction, partially offset by cash generated from operations.
On November 1, 2023, we acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $259.8 million, which equated to a total fair value of consideration transferred of $246.8 million. This acquisition's operations are included in the PD segment. For additional information, refer to Note 3. Acquisitions to our Consolidated Financial Statements.
On September 25, 2023, the Company amended its Amended and Restated Credit Agreement (the "A&R Credit Agreement") to, among other things, (a) permit the Company in connection with the acquisition of Cornell Dubilier, to incur senior priority seller financing indebtedness (the “Seller Note”) in an aggregate principal amount of $122.9 million secured by certain assets (including equity interests) acquired in connection with such acquisition and the capital stock of Cornell Dubilier, LLC (the “Acquisition Assets”), which shall mature two years after the effective date of such Seller Note (the “Seller Note Maturity Date”), (b) extends the requirement to pledge the Acquisition Assets that would otherwise constitute collateral under the Credit Agreement to the date that is 90 days after the Seller Note Maturity Date, and (c) restricts, until the Seller Note Maturity Date, the amount of dispositions and investments from the Company and certain of its subsidiaries into Cornell Dubilier, LLC and the acquired subsidiaries that constitute Acquisition Assets from exceeding $80.0 million the aggregate. All other terms remain the same as the A&R Credit Agreement dated February 8, 2023.
On February 8, 2023, we entered into the A&R Credit Agreement that amends and restates the prior Credit Agreement (the "2020 Credit Agreement"), which provides for a senior secured revolving credit facility with borrowings in an aggregate principal amount at any time outstanding not to exceed $400.0 million. As of March 31, 2024, outstanding borrowings under the Credit Facility were $180.0 million. At any time during the term of the Credit Facility, we will be permitted to increase the commitments under the Credit Facility or to establish one or more incremental term loan facilities under the New Credit Facility in an aggregate principal amount not to exceed $200.0 million for all such incremental facilities. Commitments under the Credit Facility will terminate, and loans outstanding thereunder will mature, on February 8, 2028. For additional information, refer to Note 8. Borrowings to our Consolidated Financial Statements.
On February 24, 2020, we announced that our Board of Directors had authorized a share repurchase program of up to $100 million of our common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $150 million in additional aggregate value. At March 31, 2024, we have $97.7 million remaining that may yet be repurchased under our share repurchase program. The timing and amount of any shares repurchased will be determined by us based on our evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. We are not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of our common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the three months ended March 31, 2023, the Company repurchased 433,759 shares of common stock for a total of $7.5 million. The Company did not repurchase any shares of its common stock during the three months ended March 31, 2024.
Cash flows from operating, investing, and financing activities as reflected in our Consolidated Statements of Cash Flows are summarized in the following table:
(in millions)
| Net cash flows provided by (used in): | Three Months Ended March 31, 2024 | 2023 |
|---|---|---|
| Operating activities | $17.3 | $21.9 |
| Investing activities | 3.8 | (3.9) |
| Financing activities | 13.6 | (14.3) |
| Effect of exchange rate changes on cash and cash equivalents | 0.1 | 0.1 |
| Net increase in cash and cash equivalents | $34.8 | $3.8 |
Operating Activities
Cash provided by operating activities adjusts net earnings for certain non-cash items, including impairment charges, depreciation expense, amortization of intangible assets, stock-based compensation, changes in deferred income taxes, and the effects of changes in operating assets and liabilities. The decrease in cash provided by operating activities in 2024 as compared to 2023 is primarily due to higher incentive compensation and restructuring payments in 2024.
Investing Activities
The cash provided by investing activities during 2024 was primarily driven by proceeds from the sale of intellectual property. In addition, capital expenditures were lower in 2024 as compared to 2023. The cash used in investing activities during 2023 was primarily driven by capital expenditures to support product innovation and cost savings.
In 2024, we expect capital expenditures to be in the range of 3.0% to 4.0% of revenues.
Financing Activities
Cash provided by financing activities during 2024 was primarily related to the $20.0 million net borrowing of revolving credit facility, partially offset by the $5.8 million payment of taxes related to net share settlement of equity awards. Cash used in financing activities during 2023 was primarily related to the $7.5 million of repurchases of common stock, the $6.0 million payment of taxes related to net share settlement of equity awards, and the $1.6 million payment of debt issuance costs, partially offset by proceeds of $1.4 million from the exercise of options.
Contingent Obligations
We are involved in various legal proceedings, claims, and investigations arising in the ordinary course of business. Legal contingencies are discussed in Note 13. Commitments and Contingent Liabilities to our Consolidated Financial Statements.
Critical Accounting Estimates
This discussion and analysis of results of operations and financial condition is based on our Consolidated Financial Statements, which have been prepared in conformity with U.S. GAAP. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses, and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates are revised periodically. Actual results could differ from these estimates.
The information concerning our critical accounting estimates can be found under Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on February 21, 2024. The issuance of recent accounting standards, as included in Note 2. Recent Accounting Standards to our Consolidated Financial Statements, is not expected to have a significant impact on our revenue, earnings, or liquidity.
Recent Accounting Standards
The issuance of recent accounting standards, as included in Note 2. Recent Accounting Standards to our Consolidated Financial Statements, is not expected to have a significant impact on our revenue, earnings, or liquidity.
Market risk
As filed, 434 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
During the three months ended March 31, 2024, there were no material changes to the information on market risk exposure disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023. For a discussion of our exposure to market risk as of December 31, 2023, refer to Item 7A, Quantitative and Qualitative Disclosures about Market Risk, contained in our Annual Report on Form 10-K for the year ended December 31, 2023.
Controls and procedures
As filed, 3,193 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management has evaluated, under the supervision and with the participation of our chief executive officer ("CEO") and chief financial officer ("CFO"), the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on that evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting that occurred during the first quarter of 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. The Company is in the process of reviewing the internal control structure of an acquired business and, if necessary, will make appropriate changes as we incorporate our controls and procedures into the recently acquired business.
Inherent Limitations on Effectiveness of Controls
Our management, including the CEO and CFO, do not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, will be detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by intentionally falsified documentation, by collusion of two or more individuals within Knowles or third parties, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
Risk factors
As filed, 183 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes from the risk factors previously disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $196.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $125.5m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $69.9m | us-gaap:GrossProfit |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $20.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $43.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $4.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $2.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 90,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | $17.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $3.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $122.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $467.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $1.48bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $170.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-03-31 | $245.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $48.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-03-31 | $1.03bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001587523-24-000040. Last ingested by Listed: Nov 11, 2026, 02:23 ET. Listed shows no prices and gives no investment advice.